| Financial Year |
March 31 2023 |
| Monetary Funds |
475,180,304.01 |
| Held-for-trading Financial Assets |
45,678,761.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
463,193,437.50 |
| Advances to Suppliers |
205,018,090.90 |
| Other Receivables |
36,337,421.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,317,338,336.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
121,699,576.44 |
| Total Current Assets |
2,856,251,087.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
490,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
416,692,821.69 |
| Under-construction Projects |
59,530,853.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,615,621.64 |
| R&D expenses |
2,995,275.71 |
| Goodwill |
6,741,957.88 |
| Long-Term Deferred and Prepaid Expenses |
31,597,244.69 |
| Deferred Income Tax Assets |
58,666,159.34 |
| Other Non-Current Assets |
14,096,654.68 |
| Sub-Total of Non-Current Assets |
688,097,942.55 |
| Total Assets |
3,544,349,030.02 |
| Short-Term Loans |
595,502,516.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
249,243,546.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,984,969.45 |
| Taxes Payable |
2,143,107.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,023,675.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
209,889,694.45 |
| Other Current Liabilities |
14,728,538.16 |
| Sub-Total of Current Liabilities |
2,136,404,554.75 |
| Long-term Loans |
32,192,416.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,913,703.49 |
| Deferred Income Tax Liabilities |
3,947,274.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,660,288.41 |
| Total Liabilities |
2,204,064,843.16 |
| Paid-In Capital(Or Share Stock) |
120,701,344.00 |
| Capital Surplus |
868,807,780.25 |
| Surplus Reserve |
80,433,675.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
247,497,353.44 |
| Minority Stockholder's Interest |
24,311,476.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,315,972,710.27 |
| Owner's Equity（Stockholder's Equity） |
1,340,284,186.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,544,349,030.02 |
